Pubertal Presentation in Seven Patients with Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Autor: | Luitgard Graul-Neumann, Martin Silink, Maria Szarras-Czapnik, Jan Idkowiak, Ewa M. Malunowicz, Mehul T. Dattani, Michiel N. Kerstens, Nicole Reisch, Dominique Maiter, Nils Krone, Felicity Collins, Cedric H. L. Shackleton, Birgit Köhler, Stephen M. P. O'Riordan, Wiebke Arlt |
---|---|
Přispěvatelé: | Guided Treatment in Optimal Selected Cancer Patients (GUTS) |
Rok vydání: | 2011 |
Předmět: |
Male
Endocrinology Diabetes and Metabolism Clinical Biochemistry POINT MUTATIONS OVARIAN CYSTS Biochemistry Cohort Studies 0302 clinical medicine Endocrinology JCEM Online: Hot Topics in Translational Endocrinology Gonadal Steroid Hormones Amenorrhea Gonadal Dysgenesis 46 XY 0303 health sciences 030219 obstetrics & reproductive medicine Reverse Transcriptase Polymerase Chain Reaction MEIOSIS Menstruation Phenotype CYP17A1 RC Internal medicine Androgens Female Steroids Glucocorticoid medicine.drug DISORDERED STEROIDOGENESIS medicine.medical_specialty Adolescent Hormone Replacement Therapy medicine.drug_class 030209 endocrinology & metabolism Biology Young Adult 03 medical and health sciences AROMATASE DEFICIENCY Internal medicine medicine Adrenal insufficiency Humans Congenital adrenal hyperplasia Genitalia CYTOCHROME-P450 OXIDOREDUCTASE NADPH-Ferrihemoprotein Reductase Hydrocortisone 030304 developmental biology Adrenal Hyperplasia Congenital Ovary Puberty Biochemistry (medical) Infant Newborn ANTLEY-BIXLER-SYNDROME medicine.disease GENE Estrogen Sex steroid Karyotyping Aromatase deficiency RETINOIC ACID HOMEOSTASIS INACTIVATING MUTATIONS |
Zdroj: | The Journal of Clinical Endocrinology and Metabolism The Journal of Clinical Endocrinology & Metabolism; Vol 96 Journal of Clinical Endocrinology and Metabolism, 96(3), E453-E462. ENDOCRINE SOC |
ISSN: | 1945-7189 0163-769X 0021-972X |
DOI: | 10.1210/edrv.32.1.zef155a |
Popis: | Adolescents with oxidoreductase deficiency present with impaired pubertal development, manifesting in girls with hypergonadotropic hypogonadism and ovarian cysts while boys may show delayed but spontaneous pubertal progression. Context: P450 oxidoreductase (POR) is a crucial electron donor to all microsomal P450 cytochrome (CYP) enzymes including 17α-hydroxylase (CYP17A1), 21-hydroxylase (CYP21A2) and P450 aromatase. Mutant POR causes congenital adrenal hyperplasia with combined glucocorticoid and sex steroid deficiency. P450 oxidoreductase deficiency (ORD) commonly presents neonatally, with disordered sex development in both sexes, skeletal malformations, and glucocorticoid deficiency. Objective: The aim of the study was to describe the clinical and biochemical characteristics of ORD during puberty. Design: Clinical, biochemical, and genetic assessment of seven ORD patients (five females, two males) presenting during puberty was conducted. Results: Predominant findings in females were incomplete pubertal development (four of five) and large ovarian cysts (five of five) prone to spontaneous rupture, in some only resolving after combined treatment with estrogen/progestin, GnRH superagonists, and glucocorticoids. Pubertal development in the two boys was more mildly affected, with some spontaneous progression. Urinary steroid profiling revealed combined CYP17A1 and CYP21A2 deficiencies indicative of ORD in all patients; all but one failed to mount an appropriate cortisol response to ACTH stimulation indicative of adrenal insufficiency. Diagnosis of ORD was confirmed by direct sequencing, demonstrating disease-causing POR mutations. Conclusion: Delayed and disordered puberty can be the first sign leading to a diagnosis of ORD. Appropriate testosterone production during puberty in affected boys but manifest primary hypogonadism in girls with ORD may indicate that testicular steroidogenesis is less dependent on POR than adrenal and ovarian steroidogenesis. Ovarian cysts in pubertal girls may be driven not only by high gonadotropins but possibly also by impaired CYP51A1-mediated production of meiosis-activating sterols due to mutant POR. |
Databáze: | OpenAIRE |
Externí odkaz: |